ENZO BIOCHEM, INC. Deferred Tax Assets, Net of Valuation Allowance
ENZO BIOCHEM, INC. had Deferred Tax Assets, Net of Valuation Allowance of $29.66 million as of 2024-07-31, per its 10-K filed 2024-10-29.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2024-10-29
- 2024-07-31: Deferred Tax Assets, Net of Valuation Allowance $29.66M.
- 2023-07-31: Deferred Tax Assets, Net of Valuation Allowance $26.68M.
- 2022-07-31: Deferred Tax Assets, Net of Valuation Allowance $34.61M.
- 2021-07-31: Deferred Tax Assets, Net of Valuation Allowance $29.87M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2024-07-31 | $29.66M 10-K · filed 2024-10-29 |
| 2023-07-31 | $26.68M 10-K · filed 2024-10-29 |
| 2022-07-31 | $34.61M 10-K · filed 2022-10-14 |
| 2021-07-31 | $29.87M 10-K · filed 2022-10-14 |
| 2020-07-31 | $30.08M 10-K · filed 2021-10-12 |